Funding enables retailers to offer point‑of‑sale discounts that help farmers use products that reduce losses and protect ...

The "Stabilized Urea Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035" has been added to ...

This study delivers an in-depth evaluation across technology categories (water-soluble fertilizers, controlled-release fertilizers, slow-release fertilizers, micronutrients, liquid formulations), ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the oral Bruton's tyrosine kinase (BTK) inhibitor remibrutinib (Rhapsido, Novartis Pharmaceuticals UK) for adults with ...

In “Spider-Man: Brand New Day,” Peter Parker invents new technology that could accidentally change the future of the Marvel Cinematic Universe. The tech, created after a conversation with Bruce Banner ...

The first experiment was conducted in a greenhouse using a completely randomized design with five treatments and four replications. Treatments consisted of a control (without N application), urea (Ur) ...

The global N-(n-propyl) thiophosphoric triamide (NPPT) urease inhibitor market is experiencing rapid expansion as agricultural producers seek to improve nitrogen use efficiency, reduce ...

Please provide your email address to receive an email when new articles are posted on . Iptacopan received traditional FDA approval for treating adults with immunoglobulin A nephropathy. The ...

The Food and Drug Administration on Thursday approved a new cholesterol pill from Merck that works in a different way from statins. The daily pill, called Lipfendra, is known as a PCSK9 inhibitor — a ...

Trials of current B cell-directed therapies and an investigational inhibitor of the alternative complement pathway demonstrate proteinuria reduction in patients with IgA nephropathy. Targeting ...

WEE1 functions as a checkpoint gatekeeper; inhibition forces cell-cycle progression despite unrepaired DNA damage, leveraging tumor replication stress and p53/repair deficits to induce mitotic ...

For patients with advanced solid tumors harboring specific genetic alterations, the first-in-class synthetic lethal combination of WEE1 inhibitor zedoresertib plus PKMYT1 inhibitor lunresertib ...